A major producer of breast implants is stopping the sale and distribution of their textured products, amid growing links to a rare and deadly cancer. The FDA requested the recall from Allergan after a "significant increase" in cases of a particular lymphoma. The FDA says the risk of lymphoma with Allergan's Biocell textured implants is approximately six times that of other manufacturers who are marketing in the U.S. Anna Werner reports.
